ERBB2 and neoplasm: Although genetic susceptibility markers influence differently the prognosis as well as the risk of breast cancer based on the ER, PR, and/or HER2 status[12,15–28], there are no genetic association studies on the prognosis of breast cancer which consider the heterogeneity of intrinsic tumor subtypes composed of various combinations of ER, PR, and HER2 status.